These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19879067)

  • 21. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan SC
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):831-8. PubMed ID: 17560737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
    Komaki R; Swann RS; Ettinger DS; Glisson BS; Sandler AB; Movsas B; Suh J; Byhardt RW
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):342-50. PubMed ID: 15890573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.
    Hedde JP; Neuhaus T; Schüller H; Metzler U; Schmidt-Wolf IG; Kleinschmidt R; Losem C; Lange O; Grohe C; Stier S; Ko YD
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):839-44. PubMed ID: 17379446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors.
    Zhang P; Sun M; Qiu R; Tang L; Dou G; Xu B
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):971-8. PubMed ID: 21305287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
    Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.
    Pugh TJ; Chen C; Rabinovitch R; Eckhardt SG; Rusthoven KE; Swing R; Raben D
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):521-6. PubMed ID: 20133082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation Study.
    Kim MM; Camelo-Piragua S; Schipper M; Tao Y; Normolle D; Junck L; Mammoser A; Betz BL; Cao Y; Kim CJ; Heth J; Sagher O; Lawrence TS; Tsien CI
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):305-11. PubMed ID: 26853339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial.
    Melichar B; Casado E; Bridgewater J; Bennouna J; Campone M; Vitek P; Delord JP; Cerman J; Salazar R; Dvorak J; Sguotti C; Urban P; Viraswami-Appanna K; Tan E; Tabernero J
    Br J Cancer; 2011 Nov; 105(11):1646-53. PubMed ID: 22027708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of GRN1005 in recurrent malignant glioma.
    Drappatz J; Brenner A; Wong ET; Eichler A; Schiff D; Groves MD; Mikkelsen T; Rosenfeld S; Sarantopoulos J; Meyers CA; Fielding RM; Elian K; Wang X; Lawrence B; Shing M; Kelsey S; Castaigne JP; Wen PY
    Clin Cancer Res; 2013 Mar; 19(6):1567-76. PubMed ID: 23349317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
    Nayak L; DeAngelis LM; Robins HI; Govindan R; Gadgeel S; Kelly K; Rigas JR; Peereboom DM; Rosenfeld SS; Muzikansky A; Zheng M; Urban P; Abrey LE; Omuro A; Wen PY
    Cancer; 2015 Dec; 121(23):4165-72. PubMed ID: 26308485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.
    Phillips TL; Scott CB; Leibel SA; Rotman M; Weigensberg IJ
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):339-48. PubMed ID: 7673021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer.
    Schild SE; Wong WW; Vora SA; Halyard MY; Wheeler RH
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):729-34. PubMed ID: 12377324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative dosing schedules and administration updates for ixabepilone.
    Kossoff E
    J Oncol Pharm Pract; 2011 Sep; 17(3):203-8. PubMed ID: 20215481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
    Tsien C; Moughan J; Michalski JM; Gilbert MR; Purdy J; Simpson J; Kresel JJ; Curran WJ; Diaz A; Mehta MP;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):699-708. PubMed ID: 18723297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epothilones: clinical update and future directions.
    Donovan D; Vahdat LT
    Oncology (Williston Park); 2008 Apr; 22(4):408-16; discussion 416, 421, 424 passim. PubMed ID: 18472615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of epothilone B (patupilone) in refractory lymphoma and advanced solid tumors in dogs.
    Meier V; Geigy C; Grosse N; McSheehy P; Rohrer Bley C
    J Vet Intern Med; 2013; 27(1):120-5. PubMed ID: 23205945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.